benzimidazole has been researched along with Leishmaniasis in 1 studies
1H-benzimidazole : The 1H-tautomer of benzimidazole.
Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boiani, M | 1 |
| Boiani, L | 1 |
| Merlino, A | 1 |
| Hernández, P | 1 |
| Chidichimo, A | 1 |
| Cazzulo, JJ | 1 |
| Cerecetto, H | 1 |
| González, M | 1 |
1 other study available for benzimidazole and Leishmaniasis
| Article | Year |
|---|---|
Second generation of 2H-benzimidazole 1,3-dioxide derivatives as anti-trypanosomatid agents: synthesis, biological evaluation, and mode of action studies.
Topics: Animals; Benzimidazoles; Cell Line; Cell Survival; Chagas Disease; Glucose; Leishmania braziliensis; | 2009 |